Title: Characterisation of islet antibody-negative type 1 diabetes mellitus in Indian children
| dc.contributor.author | Jayakrishnan C. Menon | |
| dc.contributor.author | Pratibha Singh | |
| dc.contributor.author | Archana Archana | |
| dc.contributor.author | Uma Kanga | |
| dc.contributor.author | Preeti Lata Singh | |
| dc.contributor.author | Medha Mittal | |
| dc.contributor.author | Atul Garg | |
| dc.contributor.author | Anju Seth | |
| dc.contributor.author | Vijayalakshmi Bhatia | |
| dc.contributor.author | Preeti Dabadghao | |
| dc.contributor.author | Siddhnath Sudhanshu | |
| dc.contributor.author | Ruchira Vishwakarma | |
| dc.contributor.author | Shivendra Verma | |
| dc.contributor.author | Shipra Kumar Singh | |
| dc.contributor.author | Eesh Bhatia | |
| dc.date.accessioned | 2026-02-19T11:37:22Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Aims: Islet antibody-negative type 1 diabetes mellitus (T1DM) has not been well characterised. We determined the frequency of antibody-negative T1DM and compared it with antibody-positive T1DM in a cohort of north Indian children. Methods: In a multi-centre, prospective, observational study, 176 Indian children (age 1–18 years) were assessed within 2 weeks of diagnosis of T1DM. Antibodies against GAD65 (GADA), islet antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A), were estimated using validated ELISA. HLA-DRB1, DQA1 and DQB1 alleles were studied by Luminex-based typing. Monogenic diabetes was determined by targeted next-generation sequencing using the Illumina platform. Results: After excluding 12 children with monogenic diabetes, GADA, IA-2A and ZnT8A were present in 124 (76%), 60 (37%) and 62 (38%) children, respectively, while 24 (15%) were negative for all antibodies. A single antibody (most frequently GADA) was present in 68 (41%) of children, while all three antibodies were found in 34 (21%). Islet antibody-negative T1DM (n = 24, 15%) did not differ from antibody-positive children in their clinical features, HbA1c or plasma C-peptide, both at onset or after 1 year follow-up (available in 62 children). The frequency of other organ-specific antibodies or high-risk HLA-DR and DQ alleles were also similar. Children with a single islet antibody did not differ from those with multiple antibodies. Conclusions: The frequency of various islet-antibodies, in isolation and combination, differed considerably from studies among children of European descent with T1DM. Children with T1DM who were islet antibody-negative were indistinguishable from those who were antibody-positive. © 2024 Diabetes UK. | |
| dc.identifier.doi | 10.1111/dme.15477 | |
| dc.identifier.issn | 7423071 | |
| dc.identifier.uri | https://doi.org/10.1111/dme.15477 | |
| dc.identifier.uri | https://dl.bhu.ac.in/bhuir/handle/123456789/64399 | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.subject | human leucocyte antigen | |
| dc.subject | idiopathic type 1 diabetes | |
| dc.subject | islet-antibody | |
| dc.subject | type 1 diabetes mellitus | |
| dc.subject | type 1B diabetes | |
| dc.title | Characterisation of islet antibody-negative type 1 diabetes mellitus in Indian children | |
| dc.type | Publication | |
| dspace.entity.type | Article |
